K-Ras Activation Induces Differential Sensitivity to Sulfur Amino Acid Limitation and Deprivation and to Oxidative and Anti-Oxidative Stress in Mouse Fibroblasts.
BACKGROUND
Cancer cells have an increased demand for amino acids and require transport even of non-essential amino acids to support their increased proliferation rate. Besides their major role as protein synthesis precursors, the two proteinogenic sulfur-containing amino acids, methionine and cysteine, play specific biological functions. In humans, methionine is essential for cell growth and development and may act as a precursor for cysteine synthesis. Cysteine is a precursor for the biosynthesis of glutathione, the major scavenger for reactive oxygen species.


RESULTS
We study the effect of K-ras oncogene activation in NIH3T3 mouse fibroblasts on transport and metabolism of cysteine and methionine. We show that cysteine limitation and deprivation cause apoptotic cell death (cytotoxic effect) in both normal and K-ras-transformed fibroblasts, due to accumulation of reactive oxygen species and a decrease in reduced glutathione. Anti-oxidants glutathione and MitoTEMPO inhibit apoptosis, but only cysteine-containing glutathione partially rescues the cell growth defect induced by limiting cysteine. Methionine limitation and deprivation has a cytostatic effect on mouse fibroblasts, unaffected by glutathione. K-ras-transformed cells-but not their parental NIH3T3-are extremely sensitive to methionine limitation. This fragility correlates with decreased expression of the Slc6a15 gene-encoding the nutrient transporter SBAT1, known to exhibit a strong preference for methionine-and decreased methionine uptake.


CONCLUSIONS
Overall, limitation of sulfur-containing amino acids results in a more dramatic perturbation of the oxido-reductive balance in K-ras-transformed cells compared to NIH3T3 cells. Growth defects induced by cysteine limitation in mouse fibroblasts are largely-though not exclusively-due to cysteine utilization in the synthesis of glutathione, mouse fibroblasts requiring an exogenous cysteine source for protein synthesis. Therapeutic regimens of cancer involving modulation of methionine metabolism could be more effective in cells with limited methionine transport capability.
SYSBIO, Centre of Systems Biology, Milan, Italy.|Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.
Gaia
G
De Sanctis
SYSBIO, Centre of Systems Biology, Milan, Italy.|Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.
Michela
M
Spinelli
SYSBIO, Centre of Systems Biology, Milan, Italy.|Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.
Marco
M
Vanoni
SYSBIO, Centre of Systems Biology, Milan, Italy.|Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.
Elena
http://orcid.org/0000-0002-3190-7671
E
Sacco
Biochem J. 2003 Dec 15;376(Pt 3):e9-10
14656216
FASEB J. 2010 May;24(5):1442-53
20019239
Science. 1956 Feb 24;123(3191):309-14
13298683
J Urol. 2005 Sep;174(3):1065-9; discussion 1069-70
16094059
J Nutr. 2004 Mar;134(3):489-92
14988435
Proc Natl Acad Sci U S A. 1966 Jul;56(1):156-63
5229844
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
10592173
Oncogene. 2006 Aug 31;25(39):5391-404
16607279
Crit Rev Clin Lab Sci. 2006;43(2):143-81
16517421
Database (Oxford). 2015 Jul 24;2015:bav068
26209309
Biotechnol Adv. 2012 Jan-Feb;30(1):16-29
21736933
Annu Rev Nutr. 2004;24:539-77
15189131
Int J Mol Sci. 2015 Sep 22;16(9):22830-55
26402672
Cell Death Dis. 2014 Dec 04;5:e1561
25476909
Mol Aspects Med. 2009 Feb-Apr;30(1-2):42-59
18601945
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8788-93
20421486
Clin Cancer Res. 2015 Apr 15;21(8):1828-34
25878364
J Clin Oncol. 2008 May 1;26(13):2139-46
18390968
Science. 1997 Jan 17;275(5298):343-9
8994024
Mol Aspects Med. 2013 Apr-Jun;34(2-3):197-219
23506866
Nat Rev Drug Discov. 2015 Aug;14(8):543-60
26111766
Cell Metab. 2008 Jan;7(1):11-20
18177721
Sci Transl Med. 2014 Jan 29;6(221):221ra15
24477002
Nat Rev Cancer. 2007 Apr;7(4):295-308
17384584
Ann N Y Acad Sci. 2016 Jan;1363:68-79
26916321
Nutr Cancer. 2006;54(2):202-8
16898864
Biochem Biophys Res Commun. 2005 Nov 25;337(3):892-900
16226721
J Clin Oncol. 2015 Nov 1;33(31):3650-9
26371146
Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7
26656494
Cold Spring Harb Perspect Med. 2015 Apr 01;5(4):null
25833940
Clin Cancer Res. 2015 Apr 15;21(8):1797-801
25878360
Science. 2010 Dec 3;330(6009):1340-4
21127244
Nutr Cancer. 2002;42(2):158-66
12416254
Nucleic Acids Res. 2011 Jan;39(Database issue):D945-50
20952405
Am J Clin Nutr. 2007 Oct;86(4):1120-5
17921391
Oncogene. 2015 Jan 8;34(2):135-43
24469033
Cell. 2011 Mar 4;144(5):646-74
21376230
Trends Biochem Sci. 2010 Aug;35(8):427-33
20570523
Nat Biotechnol. 2013 May;31(5):419-25
23455439
Cancer Sci. 2010 Jan;101(1):173-9
19900191
Int J Cancer. 2014 Sep 1;135(5):1060-71
24531984
J Biochem. 2015 Aug;158(2):91-9
26100833
Biotechnol Adv. 2012 Jan-Feb;30(1):233-43
21620943
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
26476454
Cancer Cell. 2006 Sep;10(3):241-52
16959615
Oxid Med Cell Longev. 2013;2013:956792
23738047
Int J Biochem Cell Biol. 2002 May;34(5):439-58
11906817
Nature. 2013 Apr 4;496(7443):101-5
23535601
Mol Cell Biol. 1985 Oct;5(10):2836-41
3915535
Cell Metab. 2014 May 6;19(5):780-94
24746804
Oncogene. 2000 Apr 20;19(17):2147-54
10815806
Prog Clin Biol Res. 1988;276:265-86
3051021
J Pharmacol Sci. 2008 Nov;108(3):227-38
19008644
Anticancer Res. 1987 Jul-Aug;7(4A):639-52
3310850
J Nutr. 2003 Jun;133(6 Suppl 1):2068S-2072S
12771367
Cell. 2012 Apr 27;149(3):656-70
22541435
Biomed Res Int. 2014;2014:787365
25309926
Biochim Biophys Acta. 2016 Oct;1863(10):2531-9
26724577
Nutr Rev. 2013 Jul;71(7):413-32
23815141
Nat Rev Cancer. 2013 Aug;13(8):572-83
23822983
Arch Biochem Biophys. 1959 Apr;81(2):448-55
13638009
Anticancer Res. 2008 Sep-Oct;28(5A):2541-4
19035276
Rejuvenation Res. 2009 Dec;12(6):421-34
20041736
PLoS Genet. 2016 Mar 15;12(3):e1005931
26978032
Cancer Metab. 2016 May 02;4:9
27141305
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
18032601
Cell. 2008 Sep 5;134(5):703-7
18775299
Cell Death Differ. 2015 Mar;22(3):377-88
25257172
J Nutr Biochem. 1990 May;1(5):228-37
15539209
Nat Rev Mol Cell Biol. 2012 Mar 07;13(4):270-6
22395772
Nat Protoc. 2006;1(6):3159-65
17406579
Biochem Pharmacol. 2002 Sep;64(5-6):1019-26
12213601
Oncotarget. 2016 Aug 9;7(32):52017-52031
27409831
Expert Opin Ther Pat. 2012 Nov;22(11):1263-87
23009088
Nat Commun. 2013;4:2236
23900562
Free Radic Biol Med. 1999 Nov;27(9-10):916-21
10569624
Handb Exp Pharmacol. 2016;233:321-53
25912014
Cell. 2015 Jul 30;162(3):478-87
26232220
Mol Syst Biol. 2011 Aug 16;7:523
21847114
Biochem J. 2006 Jan 1;393(Pt 1):421-30
16185194
Clin Cancer Res. 2000 Feb;6(2):643-53
10690550
Nature. 2011 Nov 20;481(7381):380-4
22101433
Biochim Biophys Acta. 2010 Feb;1797(2):314-23
19931505
Front Physiol. 2012 Sep 12;3:362
22988443
Arch Physiol Biochem. 2007 Oct-Dec;113(4-5):234-58
18158646
J Nucl Med. 1995 Feb;36(2):252-8
7830126
Cancer Treat Rev. 2003 Dec;29(6):489-99
14585259
J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S73-7
18336669
Cancer Treat Rev. 2012 Oct;38(6):726-36
22342103
Cancer Res. 2012 Jul 15;72(14):3499-511
22802077